Literature DB >> 19841536

Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.

Sophia Bornstein1, Ruth White, Stephen Malkoski, Masako Oka, Gangwen Han, Timothy Cleaver, Douglas Reh, Peter Andersen, Neil Gross, Susan Olson, Chuxia Deng, Shi-Long Lu, Xiao-Jing Wang.   

Abstract

Smad4 is a central mediator of TGF-beta signaling, and its expression is downregulated or lost at the malignant stage in several cancer types. In this study, we found that Smad4 was frequently downregulated not only in human head and neck squamous cell carcinoma (HNSCC) malignant lesions, but also in grossly normal adjacent buccal mucosa. To gain insight into the importance of this observation, we generated mice in which Smad4 was deleted in head and neck epithelia (referred to herein as HN-Smad4-/- mice) and found that they developed spontaneous HNSCC. Interestingly, both normal head and neck tissue and HNSCC from HN-Smad4-/- mice exhibited increased genomic instability, which correlated with downregulated expression and function of genes encoding proteins in the Fanconi anemia/Brca (Fanc/Brca) DNA repair pathway linked to HNSCC susceptibility in humans. Consistent with this, further analysis revealed a correlation between downregulation of Smad4 protein and downregulation of the Brca1 and Rad51 proteins in human HNSCC. In addition to the above changes in tumor epithelia, both normal head and neck tissue and HNSCC from HN-Smad4-/- mice exhibited severe inflammation, which was associated with increased expression of TGF-beta1 and activated Smad3. We present what we believe to be the first single gene-knockout model for HNSCC, in which both HNSCC formation and invasion occurred as a result of Smad4 deletion. Our results reveal an intriguing connection between Smad4 and the Fanc/Brca pathway and highlight the impact of epithelial Smad4 loss on inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841536      PMCID: PMC2769185          DOI: 10.1172/JCI38854

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

Review 1.  Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

Authors:  Peter M Siegel; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

Review 2.  Oncogenes and tumour suppressors take on centrosomes.

Authors:  Kenji Fukasawa
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

3.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.

Authors:  X Xu; S G Brodie; X Yang; Y H Im; W T Parks; L Chen; Y X Zhou; M Weinstein; S J Kim; C X Deng
Journal:  Oncogene       Date:  2000-04-06       Impact factor: 9.867

5.  A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages.

Authors:  K F Tang; S Y Tan; S H Chan; S M Chong; K S Loh; L K Tan; H Hu
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

Review 6.  Distinct roles of individual Smads in skin carcinogenesis.

Authors:  Sophia Bornstein; Kristina Hoot; Gang-Wen Han; Shi-Long Lu; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2007-08       Impact factor: 4.784

7.  Genetic abnormalities associated with nodal metastasis in head and neck cancer.

Authors:  Volkert B Wreesmann; Dorothy Wang; Andy Goberdhan; Mukesh Prasad; Ivan Ngai; Erik A Schnaser; Peter G Sacks; Bhuvanesh Singh
Journal:  Head Neck       Date:  2004-01       Impact factor: 3.147

8.  TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.

Authors:  Irwin M Liu; Stephen H Schilling; Kristin A Knouse; Lisa Choy; Rik Derynck; Xiao-Fan Wang
Journal:  EMBO J       Date:  2008-12-18       Impact factor: 11.598

9.  Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.

Authors:  Savita Bharathy; Wen Xie; Jonathan M Yingling; Michael Reiss
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

Review 10.  Inflammation: gearing the journey to cancer.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Mutat Res       Date:  2008-03-16       Impact factor: 2.433

View more
  117 in total

1.  Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.

Authors:  Yuk-Kwan Chen; Anderson Hsien-Cheng Huang; Pei-Hsun Cheng; Shang-Hsun Yang; Li-Min Lin
Journal:  Clin Oral Investig       Date:  2012-06-06       Impact factor: 3.573

2.  Epithelial stem cell mutations that promote squamous cell carcinoma metastasis.

Authors:  Ruth A White; Jill M Neiman; Anand Reddi; Gangwen Han; Stanca Birlea; Doyel Mitra; Laikuan Dionne; Pam Fernandez; Kazutoshi Murao; Li Bian; Stephen B Keysar; Nathaniel B Goldstein; Ningjing Song; Sophia Bornstein; Zheyi Han; Xian Lu; Joshua Wisell; Fulun Li; John Song; Shi-Long Lu; Antonio Jimeno; Dennis R Roop; Xiao-Jing Wang
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 3.  Lessons learned from radiation oncology clinical trials.

Authors:  Fei-Fei Liu; Paul Okunieff; Eric J Bernhard; Helen B Stone; Stephen Yoo; C Norman Coleman; Bhadrasain Vikram; Martin Brown; John Buatti; Chandan Guha
Journal:  Clin Cancer Res       Date:  2013-09-16       Impact factor: 12.531

Review 4.  Cancer Stem Cells in Squamous Cell Carcinoma.

Authors:  Zhe Jian; Alexander Strait; Antonio Jimeno; Xiao-Jing Wang
Journal:  J Invest Dermatol       Date:  2016-11-24       Impact factor: 8.551

5.  Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.

Authors:  Ariel L Hernandez; Ying Wang; Hilary L Somerset; Stephen B Keysar; Dara L Aisner; Carrie Marshall; Daniel W Bowles; Sana D Karam; David Raben; Antonio Jimeno; Marileila Varella-Garcia; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2019-01-16       Impact factor: 4.784

6.  Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.

Authors:  Karuna Mittal; Angela Ogden; Michelle D Reid; Padmashree C G Rida; Sooryanarayana Varambally; Ritu Aneja
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.

Authors:  Haixia Cheng; Elana J Fertig; Hiroyuki Ozawa; Hiromitsu Hatakeyama; Jason D Howard; Jimena Perez; Michael Considine; Manjusha Thakar; Ruchira Ranaweera; Gabriel Krigsfeld; Christine H Chung
Journal:  Cancer Biol Ther       Date:  2015-06-05       Impact factor: 4.742

8.  Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy.

Authors:  Rong Zhong; Matt Pytynia; Charles Pelizzari; Michael Spiotto
Journal:  Cancer Res       Date:  2014-02-13       Impact factor: 12.701

9.  Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment.

Authors:  Ayman J Oweida; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Natalie Serkova; Sana D Karam
Journal:  J Vis Exp       Date:  2019-04-22       Impact factor: 1.355

Review 10.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.